{"id":551289,"date":"2026-03-24T21:51:48","date_gmt":"2026-03-24T20:51:48","guid":{"rendered":"https:\/\/medizinonline.com\/?p=551289"},"modified":"2026-03-24T21:52:29","modified_gmt":"2026-03-24T20:52:29","slug":"anticorps-bispecifiques-mecanismes-preuves-et-role-futur","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/anticorps-bispecifiques-mecanismes-preuves-et-role-futur\/","title":{"rendered":"Anticorps bisp\u00e9cifiques &#8211; M\u00e9canismes, preuves et r\u00f4le futur"},"content":{"rendered":"\n<p><strong>Les anticorps bisp\u00e9cifiques repr\u00e9sentent une avanc\u00e9e th\u00e9rapeutique importante dans le traitement des lymphomes \u00e0 cellules B agressifs. En ciblant les lymphocytes T contre les lymphocytes B malins, ils ouvrent de nouvelles options pour les patients qui ne r\u00e9pondent plus aux th\u00e9rapies \u00e9tablies. Leur utilisation clinique rapide soul\u00e8ve la question du r\u00f4le qu&#8217;ils joueront \u00e0 l&#8217;avenir dans la norme th\u00e9rapeutique.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fanticorps-bispecifiques-mecanismes-preuves-et-role-futur%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les anticorps bisp\u00e9cifiques repr\u00e9sentent une avanc\u00e9e th\u00e9rapeutique importante dans le traitement des lymphomes \u00e0 cellules B agressifs. En ciblant les lymphocytes T contre les lymphocytes B malins, ils ouvrent de&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fanticorps-bispecifiques-mecanismes-preuves-et-role-futur%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":551297,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Lymphomes \u00e0 cellules B  ","footnotes":""},"category":[11527,11531,11373,11389,11549],"tags":[90086,90143,90118,90089,90128,90116,90140,90100,90137,90129,90121,90125,90136,90096,23437,90091,90106,73195,54179,90114,90110,90141,90132,90134,54428,90108,90142,90123,90112,90138,90102,90139,12573,79795,27580,90094],"powerkit_post_featured":[],"class_list":["post-551289","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-formation-continue","category-hematologie","category-oncologie","category-rx-fr","tag-activation-des-cellules-t","tag-adn-tumoral-circulant-ctdna","tag-anticorps-bispecifiques-cd20xcd3","tag-charge-tumorale","tag-charge-tumorale-biomarqueurs","tag-des-augmentations-precoces-de-cytokines","tag-diagnostic-biomarqueurs","tag-dlbcl-recidivant-refractaire-r-r-dlbcl","tag-dosage-par-etapes","tag-epcoritamab","tag-facteurs-associes-aux-tumeurs-densite-de-cd20","tag-fitness-des-cellules-t","tag-glofitamab","tag-hla-dr","tag-lymphome-a-cellules-b","tag-lymphome-diffus-a-grandes-cellules-b-dlbcl","tag-lymphome-folliculaire-fl","tag-lymphomes-a-cellules-b","tag-lymphomes-non-hodgkiniens","tag-marqueurs-dactivation-cd69","tag-marqueurs-depuisement-pd-1","tag-mosunetuzumab","tag-neurotoxicite-de-licans","tag-polatuzumab-vedotin","tag-profil-des-cytokines","tag-profil-precoce-des-cytokines-inflammatoires","tag-profils-de-cytokines-il-6-ifn-","tag-recrutement-de-cellules-t","tag-signatures-de-proliferation-des-cellules-t","tag-substances-actives-etudes","tag-synapse-immunitaire-artificielle","tag-syndrome-de-liberation-de-cytokines-crs","tag-therapie-fr","tag-therapie-par-cellules-car-t","tag-therapie-par-les-cellules-car-t","tag-tim-3","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-15 06:34:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":551288,"slug":"anticorpi-bispecifici-meccanismi-prove-e-ruolo-futuro","post_title":"Anticorpi bispecifici - meccanismi, prove e ruolo futuro","href":"https:\/\/medizinonline.com\/it\/anticorpi-bispecifici-meccanismi-prove-e-ruolo-futuro\/"},"pt_PT":{"locale":"pt_PT","id":551233,"slug":"anticorpos-biespecificos-mecanismos-provas-e-papel-futuro","post_title":"Anticorpos biespec\u00edficos - mecanismos, provas e papel futuro","href":"https:\/\/medizinonline.com\/pt-pt\/anticorpos-biespecificos-mecanismos-provas-e-papel-futuro\/"},"es_ES":{"locale":"es_ES","id":551232,"slug":"anticuerpos-biespecificos-mecanismos-pruebas-y-papel-futuro","post_title":"Anticuerpos biespec\u00edficos: mecanismos, pruebas y papel futuro","href":"https:\/\/medizinonline.com\/es\/anticuerpos-biespecificos-mecanismos-pruebas-y-papel-futuro\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/551289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=551289"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/551289\/revisions"}],"predecessor-version":[{"id":551298,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/551289\/revisions\/551298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/551297"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=551289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=551289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=551289"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=551289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}